Chongqing Huapont Pharmaceutical is an API manufacturer based in United States. It holds 17 active US drug master files across a filed portfolio of 15 molecules.
| Molecule | Regulators | Docs |
|---|---|---|
| Bendamustine | US FDA | 2 |
| Isotretinoin | US FDA | 2 |
| Acitretin | US FDA | 1 |
| Acrivastine | US FDA | 1 |
| Dapsone | US FDA | 1 |
| Dimethyl Fumarate | US FDA | 1 |
| Fluticasone Propionate | US FDA | 1 |
| Levocetirizine | US FDA | 1 |
| Linezolid | US FDA | 1 |
| Moxifloxacin | US FDA | 1 |
| Naftifine | US FDA | 1 |
| Paricalcitol | US FDA | 1 |
| Roflumilast | US FDA | 1 |
| Ruxolitinib | US FDA | 1 |
| Tretinoin | US FDA | 1 |
Also appears on these molecule pages
Choose your molecules and target markets. Chongqing Huapont Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free